|
All materials on this page that have been written and produced by TAC may be reproduced and distributed at no charge and without TAC's permission, so long as the original writers are acknowledged. If you choose to modify the original documents, it must be clearly indicated what your additions are and the original authors must still be acknowledged. Please note, however, that some documents have not been produced by TAC and this notice does not apply to them.
Competition Commission Complaint Against GlaxoSmithKline and Boehringer Ingelheim
16 October 2003
The Competition Commission has announced that they have decided to refer the complaint to the Competition Tribunal, saying that GSK and BI have abused their dom
|